Conference Interview #1 of 25
The paradoxical role of family history in breast cancer risk
MDLinx
San Antonio Breast Cancer Symposium 2017
San Antonio, Texas, United States | December 05-09, 2017
“Family history can have somewhat of a paradoxical role when we look at women who have a family history and who also have one of these high-risk lesions, such as atypical hyperplasia or lobular carcinoma in situ,” says Amy C. Degnim, MD, professor of surgery, Mayo Clinic, Rochester, MN.
When considering the bigger picture, individuals with a “strong family history” of breast cancer are at increased risk of developing disease. However, once the individual is diagnosed with one of the aforementioned lesions, this family history “may not further impact their risk, unless their family history is so strong, that they undergo genetic testing and are found to have a mutation in one of these inherited genes that dramatically increases their risk.”
Family history also plays a role in breast cancer development in male patients.
From this Conference
-
2:36A look back at SABCS 2017: Overtreatment can result in lifelong complicationsResearchers from around the world gathered at the 2017 San Antonio Breast Cancer Symposium to present research that would change the way we view breast cancer.
Sheldon Feldman, MD, FACS -
2:02Breast cancer: Mortality rates in men versus womenWhen we think of breast cancer, rarely do we consider the male patient, and it might be because “men are at a dramatically lower risk for breast cancer than...
Amy C. Degnim, MD -
4:40Implementing the TEAM approach to optimize concurrent palliative careOncologists should be open to implementing the TEAM approach to provide their patients the best concurrent palliative care possible, Thomas J. Smith, MD, FACP, FASCO, FAAHPM,...
Thomas J. Smith, MD, FACP, FASCO, FAAHPM -
0:52Value of chemotherapy for patients with locoregional breast cancer recurrenceAlthough chemotherapy can positively impact patient outcomes after locoregional recurrence of breast cancer, this will generally occur only in patients with HR-negative (HR-)...
William Gradishar, MD -
5:57Exploring locoregional recurrence of breast cancerFor locoregional recurrence of breast cancer, there is no standard of care because there are so few patients in whom this occurs.
William Gradishar, MD -
1:32The benefits and hurdles of early, concurrent, palliative careThe difference between hospice care and palliative care is an important distinction to make, and the shortage in palliative care providers must be addressed if clinicians are...
Thomas J. Smith, MD, FACP, FASCO, FAAHPM
This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium 2017.
